Artificial Intelligence
April 23–25, 2018
Boston, MA • United States

Benjamin Scirica, MD

  • Director of Innovation, Cardiovascular Division, Senior Investigator, TIMI Study Group, Brigham and Women's Hospital
  • Associate Professor of Medicine, Harvard Medical School

Dr. Benjamin Scirica graduated from Harvard Medical School and trained in internal medicine and cardiovascular medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He has a Master of Public Health degree from Harvard School of Public Health. He is currently Associate Professor of Medicine at Harvard Medical School and Senior Investigator at the TIMI Study Group (an academic research organization based at Brigham and Women’s Hospital that has performed over 70 clinical trials in atherosclerotic heart disease). He is Director of Innovation in the cardiovascular division at Brigham and Women’s Hospital.

His research interests center on the identification and application of novel cardiac biomarkers and therapeutic strategies across the spectrum of cardiometabolic disease. He was principal investigator of the AVANT GARDE-TIMI 43 trial and CAMELLIA-TIMI 61 and co-investigator of the MERLIN-TIMI 36, TRA 2Pº-TIMI 50, and SAVOR-TIMI 53 trials. He is the Director of the TIMI ECG Core Laboratory, which has analyzed over 20,000 continuous and static ECGs from multiple trials in acute coronary syndromes.

Dr. Scirica has authored or co-authored over 100 peer-reviewed articles, serves on the editorial board of ACCEL, and is a reviewer for multiple journals, including The Lancet, Circulation and Journal of the American College of Cardiology (JACC). He practices in the Levine Cardiac Intensive Care Unit, cardiology in-patient service, and the Watkins Cardiovascular Clinic at Brigham and Women’s Hospital.

This speaker appears at this event: